Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.23.1
Condensed Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 38,988 $ 42,634
Accounts receivable (Note 9) 2,834 1,298
Contract asset (Note 9) 2,467 3,552
Prepaids and other current assets 1,088 1,453
Short-term investments 22 49
Total current assets 45,399 48,986
Property and equipment, net 5 6
Total assets 45,404 48,992
Current liabilities:    
Accounts payable 2,221 1,069
Accrued expenses 1,933 1,684
Total current liabilities 4,154 2,753
Warrant liabilities 0 0
Total liabilities 4,154 2,753
Commitments and contingencies (Note 3 and Note 8)
Stockholders' equity:    
Preferred stock, par value $0.0001; 10,000,000 shares authorized as of March 31, 2023 and December 31, 2022; no shares issued and outstanding at March 31, 2023 and December 31, 2022. 0 0
Common stock, par value $0.0001; 75,000,000 shares authorized as of March 31, 2023 and December 31, 2022; 20,947,830 and 20,861,315 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively. 2 2
Additional paid-in capital 118,519 117,717
Accumulated deficit (77,271) (71,480)
Total stockholders' equity 41,250 46,239
Total liabilities and stockholders' equity $ 45,404 $ 48,992